Eli Lilly
1,178 hedge funds and large institutions have $66B invested in Eli Lilly in 2016 Q2 according to their latest regulatory filings, with 97 funds opening new positions, 435 increasing their positions, 428 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 1,150 → 1,178 (+28)
2% more repeat investments, than reductions
Existing positions increased: 435 | Existing positions reduced: 428
1.1% less ownership
Funds ownership: 77.03% → 75.93% (-1.1%)
Holders
1,178
Holding in Top 10
36
Calls
$818M
Puts
$643M
Top Buyers
| 1 | +$299M | |
| 2 | +$174M | |
| 3 | +$130M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$104M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$102M |
Top Sellers
| 1 | -$1.29B | |
| 2 | -$203M | |
| 3 | -$180M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$99.7M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$94.5M |